Urologix Inc (ULGX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.0001 unch (unch) 03/28/25 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.0001 unch (unch) 09:35 ET
for Fri, Mar 28th, 2025
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
06-2014 | 06-2013 | 06-2012 | 06-2011 | 06-2010 | |
Cash Flows From Operating Activities | |||||
Net Income | -7,608 | -4,292 | -4,695 | -3,733 | -2,169 |
Depreciation Amortization | 587 | 674 | 695 | 565 | 793 |
Income taxes - deferred | -36 | 1 | 35 | N/A | N/A |
Accounts receivable | 620 | 23 | -740 | 66 | 80 |
Accounts payable and accrued liabilities | 264 | 1,760 | 2,635 | 307 | -28 |
Other Working Capital | 1,163 | 1,092 | 2,440 | 463 | -368 |
Other Operating Activity | 3,480 | -1,217 | -1,083 | -38 | 437 |
Operating Cash Flow | $-1,530 | $-1,959 | $-713 | $-2,370 | $-1,255 |
Cash Flows From Investing Activities | |||||
PPE Investments | -32 | -79 | -57 | -272 | -81 |
Net Acquisitions | N/A | -1,368 | -500 | N/A | N/A |
Purchase Sale Intangibles | -10 | -32 | N/A | N/A | N/A |
Other Investing Activity | -10 | -32 | -8 | -3 | -4 |
Investing Cash Flow | $-42 | $-1,479 | $-565 | $-275 | $-85 |
Cash Flows From Financing Activities | |||||
Common Stock Issued | N/A | 3,829 | 116 | 4 | 10 |
Financing Cash Flow | $N/A | $3,829 | $116 | $4 | $10 |
Beginning Cash Position | 2,290 | 1,899 | 3,061 | 5,702 | 7,032 |
End Cash Position | 718 | 2,290 | 1,899 | 3,061 | 5,702 |
Net Cash Flow | $-1,572 | $391 | $-1,162 | $-2,641 | $-1,330 |
Free Cash Flow | |||||
Operating Cash Flow | -1,530 | -1,959 | -713 | -2,370 | -1,255 |
Capital Expenditure | -32 | -79 | -57 | -272 | -81 |
Free Cash Flow | -1,562 | -2,038 | -770 | -2,642 | -1,336 |